| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |